Fanconi Anemia
Fanconi anemia (FA) is a rare, recessive (autosomal or X-linked) chromosomal-instability disorder, characterized by a striking hypersensitivity to DNA interstrand crosslinks (ICLs). The disease is clinically highly heterogeneous, even between monozygotic twins (Auerbach and Allen, 1991; Auerbach et al., 2001; Kook, 2005) , which dramatically complicates diagnosis. FA may be evident at birth due to congenital anomalies including aplasia of the thumb or radii and abnormal facies. Given that FA is linked with an increase in spontaneous chromosomal aberrations and cell death, these congenital anomalies are probably caused by such stochastic events in critical progenitor cells early in development. In some cases, FA may only become evident in early childhood due to renal dysfunction, abnormal pigmentation, and short stature, or the diagnosis may be made in adulthood due to the early onset of cancer. A hallmark feature of FA is pancytopenia (median age at onset 7 years) due to increased apoptosis of hematopoietic cells. The genomic instability of the surviving cells leads to myelodysplastic syndrome and acute myeloid leukemia (800-fold increased risk), with 14 years as the median age of onset (Kook, 2005) . The risk of developing solid tumors is also increased, in particular squamous cell carcinomas of the mucosal epithelia and liver tumors (Kook, 2005) . Although the median survival of FA patients is 16 years, the survival range is wide. Complications of bone-marrow failure are the most common cause of death (Alter et al., 1991; Kook, 2005) . The early onset of cancer is a common feature of FA and is attributable to chromosomal instability. In addition, there is likely to be an accelerated aging component of FA caused by increased cell death in the proliferative compartments of the body, which leads to, for example, depletion of hematopoietic reserves.
From Cellular Studies to Extreme Genetic Heterogeneity
The hypersensitivity of cells from FA patients to DNA ICL agents (such as mitomycin C or diepoxybutane) is the basis for the diagnosis of FA. ICLs are a particularly deleterious type of DNA lesion because they covalently tether both strands of the DNA helix together. This prevents strand separation, an obvious prerequisite for vital cellular processes such as DNA replication and transcription. As a result, ICLs are extremely cytotoxic, particularly for proliferating cells. Hence, crosslinking agents are among the most effective cytotoxic drugs used in cancer chemotherapy. The fact that FA cells are hypersensitive to this type of DNA damage suggests that individuals with FA have defects in ICL repair. However, increased sensitivity could also arise from abnormalities in (1) complex mechanisms to tolerate ICLs rather than repairing them (such as replication bypass), (2) the cell-cycle-control machinery, (3) mechanisms of apoptosis, or (4) metabolic inactivation of crosslinking agents. In addition, cells from FA patients are modestly sensitive to other types of DNA damage (such as ionizing radiation and oxidative stress), and FA proteins are activated in S phase of the cell cycle , suggesting a more general role in the DNA-damage response. Thus, the precise nature of the cellular processes affected in FA is unresolved.
In all cells, replication of DNA containing ICLs induces double-strand breaks (DSBs) (De Silva et al., 2000; Niedernhofer et al., 2004) . ICLs are also potent inducers of sister-chromatid exchange (SCE), suggesting that these replication-dependent DSBs are frequently resolved through the production of SCEs (Figure 1) . SCE represents the reciprocal exchange of the DNA strands between identical sister chromatids and thus only occurs during or after DNA replication. Not surprisingly, SCE requires the homologous-recombination machinery (Sonoda et al., 1999) . Dur-Fanconi anemia is characterized by hypersensitivity to DNA interstrand crosslinks (ICLs) and susceptibility to tumor formation. Despite the identification of numerous Fanconi anemia (FANC) genes, the mechanism by which proteins encoded by these genes protect a cell from DNA interstrand crosslinks remains unclear. The recent discovery of two DNA helicases that, when defective, cause Fanconi anemia tips the balance in favor of the direct involvement of the FANC proteins in DNA repair and the bypass of DNA lesions.
ing DNA repair, homologous recombination allows the DNA at a broken sister-chromatid end to pair with the identical sequence of the other sister chromatid, using this sister as a template for the synthesis of lost genetic information (Helleday, 2003) . During this intricate DNA gymnastics, crossover can occur, resulting in the exchange of DNA strands between the two sister chromatids. Importantly, DSBs in DNA that yield two broken ends (such as those caused by ionizing radiation), which can be directly recombined with one another, generally do not induce SCEs (Helleday, 2003) . However, collapse of a replication fork results in only one broken double-strand end (for structure, see Figure 2 ). These single DSBs that arise in S phase are more likely to stimulate SCE (Helleday, 2003) . These observations imply a role for DNA replication, replication-induced DSBs, and the subsequent repair of these DSBs by homologous recombination in the repair of ICLs.
In addition to SCEs, a small fraction (<5%) of cells treated with a crosslinking agent also contain a radial structure (Figure 1 ). Radial structures are created when broken sister chromatids of disparate chromosomes become erroneously fused to one another, creating a tandem array of chromosomes connected via recombined sister chromatids ( Figure  1 ). Radial-structure formation, like SCE, requires DNA replication and DSBs. Apparently, they arise if homologousrecombination-mediated repair of the DSBs does not occur and instead the DSBs are repaired through illegitimate recombination-for example by singlestrand annealing, in which broken ends with only small regions of sequence homology are joined.
The frequency of SCE in response to crosslinking agents is normal in FA (Mosedale et al., 2005; Niedzwiedz et al., 2004) ; however, the number of radial structures increases dramatically. Multiple radial structures occur in 30%-100% of FA cells treated with crosslinking agents, which is the diagnostic criteria for FA (Kook, 2005) . This implies that FA cells are defective in homologous-recombination-mediated repair of DSBs induced by ICLs (Figure 1) . Alternatively, the cells may be defective in a cell-cycle checkpoint that permits safe repair of ICLs before reentry into the cell cycle or in some other mechanism of handling ICLs during replication. With respect to the last possibility, FA cells intriguingly show a lower frequency of point mutations (single-basepair changes) than normal cells, in striking contrast to their In a cell without DNA damage, DNA replication duplicates each chromosome during S phase to create sister chromatids. Newly synthesized strands of DNA are indicated in light gray. If the chromosomal DNA contains a DNA interstrand crosslink (ICL, blue bar), replication is blocked, resulting in the creation of a DSB. In normal cells, this DSB is repaired by homologous recombination, frequently resulting in sister-chromatid exchange (see text for details and Figure 2 for mechanism). Typically, ICL repair leads to the creation of a mutation (gold bar) at or near the site of the ICL. Inset: On rare occasion (<5%) in normal cells, the ICL-induced DSB is not repaired by homologous recombination and persists (chromatid break). These DSBs can then be eliminated by illegitimate recombination with nonhomologous sequences on other chromosomes, yielding radial structures (chromatid fusions). In FA patients, treatment with DNA-damaging agents that induce ICLs results in 30%-100% of the cells in the patient showing multiple chromatid breaks and radial structures due to increased frequency of illegitimate recombination. elevated chromosomal instability. This indicates that, normally, the intact FA pathway induces point mutations while preventing chromosome aberrations. This is consistent with a mechanism that involves the bypass of a DNA lesion (which has a high chance of creating point mutations) in the FA pathway to repair ICLs. This is supported by genetic data demonstrating that error-prone translesion polymerases act in the FA pathway (Niedzwiedz et al., 2004) . Confusingly, cells from FA patients are not inherently defective in homologous recombination, as demonstrated by their capacity to trigger SCE (Mosedale et al., 2005; Niedzwiedz et al., 2004) , their relatively mild sensitivity to ionizing radiation (Bridge et al., 2005; Niedzwiedz et al., 2004) , and their ability to accurately repair a DSB created by a restriction endonuclease (Nakanishi et al., 2005) . Thus, if DNA repair is affected in FA, the defect is likely limited to a special subset of lesions (most notably ICLs) that induce replication stress. Alternatively, other findings point to impaired cell-cycle control in FA. Rather than halting DNA replication during S phase to permit ICL repair, FA cells continue DNA synthesis (Sala-Trepat et al., 2000) , risking creation of DSBs at sites of damage. In support of this, spontaneous chromosomal breaks are more common in FA cells than in wild-type cells. This is highly reminiscent of another chromosomal-instability disorder, ataxia telangiectasia, in which DNA replication is not delayed in response to radiation-induced DNA damage. ATM, the protein defective in this disorder, is a transducer in a complex signaling cascade in response to DSBs (Kurz and Lees-Miller, 2004) . In fact, one of the FA proteins (FANCD2) is an effector of ATM required for the DNA-damage checkpoint in S phase . In contrast to S phase, the G2 checkpoint is intact in FA cells (Sala-Trepat et al., 2000) . Thus, after exposure of FA cells to genotoxic stress, the majority of the cells collect in G2. In fact, G2 is prolonged in FA cells that have not been exposed to stress compared to normal cells, apparently in response to persistent endogenous DNA damage.
The phenotypic heterogeneity of this syndrome spawned a search for multiple genetic causes of FA that could be responsible for the extreme clinical variation. This search was facilitated by the exquisite sensitivity of FA cells to ICLs, which allowed for the identification of distinct complementation groups (each complementation group represents FA patients with defects in the same gene). Such complementation groups can be identified when cells (such as fibroblasts or lymphoblastoid cells) from different patients are fused together and the resulting cell population is screened for wild-type resistance to ICL damage by the complementation of each other's defect. This endeavor proved highly rewarding. The total number of FA complementation groups has now risen to 12 (FANCA, B, C, D1, D2, E, F, G, I, J, L, and very recently M; see below), with more to come. Curiously, this genetic heterogeneity does not explain the clinical heterogeneity, although a systematic analysis of a possible link between individual complementation groups and specific clinical manifestations is warranted.
From Gene Cloning to Function
The expectation that cloning the genes defective in each of the complementation groups would reveal an FA pathway turned out to be false. Sequence analysis of the first series of FA genes isolated did not yield any meaningful homology to other proteins or hints about protein function. With FANCI still awaiting identification, only 4 of the 11 cloned FA genes have provided clues about the functions of the proteins they encode. This includes FANCD1, which is identical to BRCA2, the breast cancer susceptibility gene implicated in homologous recombination (Howlett et al., 2002) ; FANCL, which encodes an E3 ubiquitin ligase implicated in the monoubiquitination of FANCD2, an essential step in the FA pathway (Meetei et al., 2003a) ; and the latest additions: FANCJ and M, both encoding DNA helicases.
Nearly all of the FA proteins physically interact in the cell, comprising an FA core complex (Garcia-Higuera et al., 2001; Meetei et al., 2003a; Meetei et al., 2004) . This complex includes FANCA, B, C, E, F, G, and L, together with as yet uncharacterized additional components (Meetei et al., 2005) . In S phase, FANCL monoubiquitinates FANCD2, a process that also requires FANCI (which is not part of the core FA complex). This in turn triggers association of FANCD2 with chromatin and its accumulation in nuclear foci. These foci are thought to demarcate the sites where DSB repair and replication bypass of DNA damage occurs. Activated FANCD2 colocalizes with factors involved in homologous-recombination-mediated DSB repair such as BRCA1, BRCA2/FANCD1, and RAD51 . RAD51 forms a nucleoprotein filament on broken DNA ends, searches for the homologous sequence in the sister chromatid, and catalyzes strand exchange required for homologous recombination. Also, replication factors such as PCNA and RPA are present in these nuclear foci. The FA core complex itself is required for translocation of FANCD2 to these nuclear foci, even after monoubiquitination is complete, and subsequently for the nuclear foci to restore replication and cell-cycle progression (Matsushita et al., 2005) . The FA core complex also interacts with the BLM-TOPOIIIα complex (Meetei et al., 2003b) . This complex is involved in the proper dissolution of double Holliday junctions, intermediates of homologous recombination (Wu et al., 2005) . Now, the newest FA proteins, FANCJ and FANCM, can be added to the FA pathway.
Identification of FANCJ
Single-nucleotide polymorphism analysis of FANCJ families pinpointed a region on chromosome 17q22 containing the culprit gene. Sequencing of candidate loci identified biallelic mutations in a gene called BRIP1 (BRCA1-interacting protein 1) or BACH1 (BRCA1-associated C-terminal helicase 1) in multiple families from the FANCJ complementation group (Levitus et al., 2005; Levran et al., 2005) . The link with FA was independently made in chicken lymphoblast DT40 cells, in which inactivation of the chicken ortholog of BRIP1 yielded an FA-like phenotype with extreme sensitivity to ICL damage (but not to UV, ionizing radiation, hydrogen peroxide, or alkylation damage) and arrest in late S/G2 in response to ICL damage (Bridge et al., 2005) . Ubiquitination of FANCD2 is normal in these cells, indicating that FANCJ acts downstream of this key event in the FA pathway. Cells deficient in both FANCJ and FANCC are more sensitive to ICL damage than cells with a mutation in just one of these FANC proteins, suggesting that the two proteins may participate in redundant DNA-repair pathways (Bridge et al., 2005) . Similar results were obtained in human cells using small interfering RNAs (siRNAs) to knock down expression of BRIP1/BACH1. These cells showed accumulation of ICL-induced chromatid breaks and radial structures, as well as γH2AX and RAD51 foci (indicative of DSBs), but normal FANCD2 ubiquitination in response to ICL damage (Litman et al., 2005) . FANCJ encodes a 5′→ 3′ helicase that interacts with the BRCT repeats of BRCA1, which mediates colocalization of the two proteins in late S/G2 (Cantor et al., 2001) . Furthermore, repair of radiation-induced DSBs is retarded in cells expressing an inactivated FANCJ helicase (Cantor et al., 2001) , suggesting a direct role for this protein in DNA repair. The recombinant human FANCJ helicase preferentially binds to and unwinds forked duplex structures but not duplexes with a singlestrand overhang or Holliday junction cruciform structures (Gupta et al., 2005) . FANCJ executes efficient strand displacement from a D loop substrate, which represents a likely intermediate in homologous recombination. Thus, it is logical to position the FANCJ helicases in the FA pathway downstream of FANCD2 monoubiquitination, the creation of ICL-induced DSBs, and formation of damage-induced nuclear foci.
Identification of FANCM
Using mass spectrometry, a 250 kDa protein that coimmunoprecipitated with the FA core complex was identified as the human ortholog of archaeabacterial protein HEF (Meetei et al., 2005) . The human ortholog of HEF is detected in cells from all FA complementation groups but not in cells from a single patient who had been excluded from all 11 complementation groups. Sequencing revealed biallelic truncations, establishing the twelfth complementation group, FANCM (Meetei et al., 2005) , and identifying the responsible gene.
FANCM/HEF contains helicase motifs and a C-terminal domain with homology to XPF and MUS81 endonucleases. The latter cleave 3′-overhanging single strands at double-strand/single-strand junctions. HEF uses both the endonuclease and helicase activities to process stalled replication forks, creating DSBs in the process (Komori et al., 2004) . Despite the fact that the yeast ortholog MPH1 lacks an endonuclease domain, genetic data implicate MPH1 in error-free homologous-recombination-mediated repair of DNA damage but not homologous recombination itself (Schurer et al., 2004) . Interestingly, human FANCM also lacks residues identified as critical for endonuclease activity of XPF. Deletion of the helicase but not the endonuclease region of chicken FANCM results in exquisite sensitivity of the cells to ICL damage and induction of ICLinduced chromosomal aberrations (Mosedale et al., 2005) .
Notably, in XPF, the converse is true: XPF has inactive helicase motifs but an active structure-specific endonuclease domain. In view of the homology between these proteins, it is intriguing to speculate that both have arisen from the same dual-function HEF ancestral helicase/nuclease and that each has specialized in one function. Importantly, XPF and its essential binding partner ERCC1 are also required for tolerance to ICL damage. It will be interesting to determine whether FANCM forms heterodimers with a partner, similar to XPF and MUS81, which form stable complexes with ERCC1 and EME1, respectively. Such a presumed partner would be a candidate for an additional FA complementation group.
Knockdown of FANCM expression in human cells by siRNA or genetic deletion of the chicken ortholog reduces monoubiquitination of FANCD2 in S phase or following ICL damage to the cells (Meetei et al., 2005; Mosedale et al., 2005) , functionally linking FANCM to the FA core complex. Biochemical studies confirmed that FANCM is a part of the FA core complex, binds to DNA, and is a DNAdependent ATPase (Meetei et al., 2005; Mosedale et al., 2005) . Notably, in contrast to its yeast and archaeabacterial orthologs, immunoisolated, tagged, recombinant FANCM does not have detectable helicase activity in an in vitro assay but does have weak translocase-like activity as measured by strand displacement from a triplex DNA substrate (Meetei et al., 2005) . FANCM is posttranslationally modified in cells exposed to ICL damage or the replication inhibitor hydroxyurea, an event that does not require the FA core complex (Meetei et al., 2005) . FANCM mutants in chicken DT40 cells are less sensitive to ICL damage than FANCC mutants (Mosedale et al., 2005) . This suggests that FANCM is not an essential component of the FA core complex, that it is involved in only a subset of the FA-corecomplex functions, or that there is some functional redundancy with other FANC proteins. These findings add a new protein with DNA binding and DNA-metabolizing activity to the FA core complex, providing strong evidence that the FA pathway participates directly in the sensing of ICLs in DNA and the repair and bypass of such lesions.
Speculative Model for the FA Reaction to Remove ICLs
The various functions now identified endow the FA pathway for the first time with bona fide DNA-metabolizing activities and point toward this pathway's participating directly in the handling of DNA-ICL damage rather than an indirect role in the cellular response to ICL lesions. Based on these new insights, we propose a tentative model for the error-prone ICL bypass/repair reaction (see Figure 2) . By analogy to transcription-coupled repair (in which stalling of an elongating RNA polymerase complex by a lesion in the transcribed strand of DNA initiates a response involving removal or displacement of the polymerase to make the damage accessible to the nucleotide excision repair machinery), we propose that arrest of DNA replication itself triggers signaling and repair of the lesion that blocks fork progression. A likely early responder to arrested replica- (1) DNA-damaging agents such as mitomycin C but also endogenous metabolic processes such as lipid peroxidation can cause interstrand crosslinks (ICLs). (2) ICLs physically block DNA replication, leading to activation of the ATR kinase, which phosphorylates a number of proteins, including FANCD2 (inset). Phosphorylated FANCD2 is monoubiquitinated by the FANCL subunit of the FA core complex (circled). This triggers the creation of nuclear foci at sites of replication stress consisting of numerous proteins involved in homologous recombination and translesion synthesis. (3) A second consequence of blocked replication is the creation of a DSB, which occurs by incision of one of the template strands upstream of the lesion by an endonuclease (depicted as scissors). (4) To separate the two template strands, a second incision is required, probably facilitated by the opening of the crosslinked substrate DNA by a helicase such as FANCM. (5) To unhook the ICL from the template strand, the second incision must occur on the same strand as the first incision but on the other side of the ICL. A likely endonuclease for this incision is ERCC1-XPF, facilitated by the single-stranded binding protein RPA, which dictates which strand is cut. (6) The second incision creates a gap and a new 3′ end that can be used to prime DNA synthesis. (7) Gap-filling DNA synthesis, probably by an error-prone translesion polymerase, is necessary to restore the damaged template strand. (8) Although these specialized polymerases permit bypass of lesions, they frequently insert incorrect bases, creating a mutation at the site of damage. (9) Once the ICL is unhooked and strand integrity is restored, DSB repair can occur by template switching, requiring the homologous-recombination machinery. This is initiated by the resection of the broken end to yield a 3′ single-strand overhang able to pair with its sister chromatid. (10-11) Repair requires the homologous-recombination machinery, including RAD51, BRCA1, BRCA2, PCNA, and RPA. The FANCJ helicase is probably involved at this step. (12) The resolution of Holliday junction recombination intermediates permits replication to continue and may or may not result in the formation of a SCE (Figure 1) . The unhooked ICL carrying a short oligonucleotide is a likely substrate for removal by the nucleotide excision repair system, or, alternatively, spontaneous hydrolysis of the glycosidic bond may detach it from the DNA, leaving a mutagenic abasic site. Deubiquitination at the end of S phase turns the pathway off (center). See text for a more detailed explanation. tion is the ATR protein kinase signal transducer (Figure 2 , step 2). One of the many targets of ATR phosphorylation is FANCD2 (Pichierri and Rosselli, 2004) . The subsequent monoubiquitination of FANCD2 by the FANCL subunit of the FA core complex (or some other E3 ligase) and translocation of FANCD2 to chromatin are dependent upon ATR activation (Andreassen et al., 2004) . This is consistent with the observation that FANCD2 is ubiquitinated during normal S phase and that the level of Ub-FANCD2 is further increased in response to ICL damage, ionizing radiation, and replicative stress caused by hydroxyurea or aphidicolin, which interfere with normal progression of the replication fork (Howlett et al., 2005) . It is important to note that measurement of steady-state levels of DNA damage predict that a genome as large as those of mammals contains many spontaneous lesions, a significant fraction of which at least transiently arrest DNA replication. Endogenous metabolism may even generate spontaneous ICLs, for instance from malondialdehyde or other byproducts of lipid peroxidation, particularly in the liver, providing a possible explanation for the increased frequency of liver tumors in FA and predicting accelerated aging of this organ, similar to that observed in crosslinkrepair-deficient ERCC1-XPF-deficient mice. Activation of ATR by arrested replication machinery also results in phosphorylation of histone H2AX, leading to the local generation of a large number of high-affinity sites for numerous proteins involved in DSB processing, including RAD51, BRCA2, PCNA, RPA, and other members of the HR repair and translesion bypass machineries, and presumably also the FA core complex (see Figure 2 , step 2). The primary function of these foci likely is to increase the local concentration of specific proteins, thereby accelerating catalysis of reactions needed for the complex DNA transactions aimed at resolving replication stress. ICLs mount a formidable challenge because they covalently link both DNA strands, hence requiring specialized machinery for resolution. This may explain the "raison d'être" of the FA pathway in vertebrate organisms, which contain multiple compartments of mitotically active cells for which the FA pathway is particularly important to prevent replication catastrophe and chromosomal aberrations.
For replication bypass of ICLs, the lesion must be released from at least one strand of DNA to permit strand separation. This necessitates endonucleolytic cleavage of one template strand on both sides of the ICL (Figure 2 , steps 3 and 5). A consequence of these incisions is the creation of a DSB (Figure 2, step 4) . The identity of the endonuclease required for the initial incision, which probably creates the DSB, is not known. Candidate endonucleases with appropriate substrate specificity include the ERCC1-XPF or related MUS81-EME1 complexes. However, replication-dependent, ICL-induced DSBs occur in the absence of either complex (De Silva et al., 2000; Dendouga et al., 2005; Niedernhofer et al., 2004) , either suggesting redundant roles for these endonucleases or possibly implicating an as yet unidentified nuclease. A second incision of the same strand, on the other side of the ICL, unhooks the lesion from that strand of DNA (Figure 2 , step 5). This incision is likely facilitated by ERCC1-XPF (Niedernhofer et al., 2004) . In support of this, ERCC1-XPF-deficient cells are exquisitely sensitive to crosslinking agents, and knockout mice show some features reminiscent of FA, including bone-marrow failure (Prasher et al., 2005) . The ERCC1-XPF endonuclease is required for other DNArepair processes, most notably nucleotide excision repair (NER), which repairs helix-distorting lesions affecting only one strand of DNA. However, the ICL sensitivity and knockout mouse phenotype are unique among NER mutants, implicating a distinct role for ERCC1-XPF in ICL repair independent of NER. Importantly, ICL damage causes the accumulation of DSBs in replicating ERCC1-XPF-deficient cells, consistent with an inability to unhook the crosslink (Niedernhofer et al., 2004) , a prerequisite for DSB repair via homologous recombination.
Endonucleolytic cleavage requires local opening of the DNA helix around the lesion, which may be facilitated by FANCM, a component of the FA core complex (Figure 2 , step 4). In addition, the single-strand DNA binding protein RPA is also required to direct strand-specific cleavage aimed at removing DNA damage by the ERCC1-XPF endonuclease (Figure 2 , step 5). RPA is in the vicinity as an integral component of the replication machinery, which perhaps needs to be displaced from the site of its arrest. The gap resulting from unhooking of the ICL must be filled in order to restore the integrity of the template strand ( Figure  2, step 7) . This probably requires a specialized translesion polymerase since the opposite strand still harbors residual damage. Replication past the lesion is expected to be error prone (Figure 2 , steps 7 and 8), explaining the mutagenic character of the FA pathway. It appears paradoxical that abolishing this mutagenic FA pathway increases cancer predisposition. A likely explanation is that the absence of the FA process wreaks more havoc on genome integrity. When any of the preceding steps fail because of a FA defect, DSBs result, triggering illegitimate recombination and radial-structure formation (Figure 1 ). This affects genome stability more than the point mutations caused by the FA process. The fact that the repair itself creates mutations illustrates the fundamental problems posed by ICLs as this type of damage affects both DNA strands, leaving no intact template for repair synthesis.
Once the integrity of the template strand is restored, DSB repair and reinitiation of replication are possible. For this to occur, the newly synthesized leading strand, interrupted by a break, must switch templates, pairing with the now intact complementary template strand (Figure 2, step 10) . This likely requires a helicase to make the template strand accessible, for which the FANCJ helicase is a suitable candidate. The homologous-recombination machinery is also required for joint molecule formation. Resolution of recombination repair intermediates permits reestablishment of the replication fork (Figure 2, steps 11 and 12 ). This probably involves the BLM-TOPOIIIα, complex, which is also associated with the FA core complex (Meetei et al., 2003b) . The remaining unhooked crosslink on one of the template strands may be removed by the nucleotide excision repair machinery, resulting in the copying of the mutation into the parental strand during gap-filling repair synthesis. Alternatively, when the ICL is no longer stabilized in duplex DNA, it may be vulnerable to spontaneous hydrolysis. This would release an oligonucleotide carrying the ICL and create a highly mutagenic abasic site in the template strand ( Figure  2, step 9) . Finally, the FA pathway is turned off by deubiquitination of FANCD2 by USP1, which is activated in late S phase (Nijman et al., 2005) . In this intricate mechanism involving the coordinated action of numerous players, an ICL that stops replication can be eliminated at the risk of creating point mutations.
Remaining Questions
Obviously, many proteins still await identification in this speculative scenario for the repair of ICLs, including the endonuclease (or endonucleases), translesion polymerase (or polymerases), and chromatin-remodeling proteins implied by the model. This leaves plenty of room for discovery of additional complementation groups of FA in the future. In vitro reconstitution of the intricate ICL repair and lesion bypass reaction poses a significant challenge as, in all likelihood, it has been a significant challenge for nature to evolve an optimal mechanism to repair ICL damage. Akin to the problems encountered by DNA replication, an untouched issue is how the transcription machinery deals with an ICL that is physically blocking elongation. This is particularly interesting because, at least to date, it appears that transcription lacks the elaborate translesion machinery that is required for lesion bypass during replication. However, homologous recombination may prove important for the resolution of arrested transcription (Aguilera, 2005) .
